# Prenetics Global Limited share price today (Prenetics Global Limited, PRE)

> Prenetics Global Limited's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. PRE · Consumer Staples · Packaged Foods · data as of 3 November 2026. Page: https://www.sectoralpha.in/us/stocks/pre

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Price: $16.19 (+9.2% in a year)
- Revenue (Jun 2026): $46.5 M (+210.7% on a year ago)
- Profit (Jun 2026): −$9.0 M
- Operating margin: −45.1% (+6.3 points on a year ago)
- ROE: −26%, FY25
- ROIC: −27.1%, against a 6.5% cost of capital: −33.6 points

Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. ## What is the Prenetics Global Limited share price today? Prenetics Global Limited's share price was $16.19 at the close on 3 November 2026. That is 17.4% below its average price over the last 200 trading days. In the last 52 weeks it traded between $12 and $26, and at that close it sat 29% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 4 weeks running. Over the last 1 year the share price moved +105% while the S&P 500 moved +21%, so it is ahead of the index over that whole period. It was last ahead over 13 weeks in the week of 9 October 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Prenetics Global Limited pay? Prenetics Global Limited pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is Prenetics Global Limited on? Prenetics Global Limited is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Prenetics Global Limited profitable? Prenetics Global Limited posted a net loss of $9.0 M in the Jun 2026 quarter. The full FY25 year was a loss of $40.0 M. That loss is 19.3% of the quarter's revenue. The same quarter a year earlier lost $12.7 M. ## How much revenue does Prenetics Global Limited make, and is it growing? Prenetics Global Limited reported $46.5 M of revenue in the Jun 2026 quarter, +210.7% on the same quarter a year earlier. That is the 2nd quarter in a row with growth on the year before. Over 4 years it has grown 64.8% a year on average. The last full year, FY25, came in at $92.4 M. The last four reported quarters add to $143 M. The quarterly figures for FY23, FY24 do not add up to the full-year total on file, so those quarters are left out of the charts and sums. FY25 revenue was $92.4 M, +479.8% on the year before. Recent pace: the last four quarters grew +159.2% on average, against 64.8% a year over the longer run, so this year is growing faster than its own long-run rate. ## How much of every $100 of sales does Prenetics Global Limited keep? Prenetics Global Limited's operating margin was −45.1% in the Jun 2026 quarter, 6.3 percentage points higher than the same quarter a year ago. Across 5 years it has been between −1,184.5% and −41.3%. The latest quarter is within that range. Why the margin moved: operating margin changed +6.3 percentage points on the year while gross margin changed +26.0 points. So the gain came mostly from the gross margin, which means input costs and prices charged. ## Is Prenetics Global Limited's profit turning into cash? Prenetics Global Limited's cash-flow history is too short to judge how much of its profit turns into cash. In FY25 its operations used $21.8 M of cash, against −$40.0 M of profit. After $208 K of spending on assets, free cash was −$22.0 M: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Prenetics Global Limited's cash go? Prenetics Global Limited does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $1.6 M on assets over the last 3 years. Averaged over those years that is 0.6% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $1.6 M over the last 3 years. In short: most of the cash goes on covering the loss, not on new assets; spending on assets is small next to it. ## What is Prenetics Global Limited's P/E ratio, and how does it compare with its own history? Prenetics Global Limited has no P/E right now, because its earnings are negative. The revenue and margin sections are where a turn would show first. Measured against sales instead, the market values Prenetics Global Limited at 3.0× its FY25 revenue of $92.4 M. The P/E comes back here once profit turns positive. ## Is the Prenetics Global Limited business getting better or worse? Prenetics Global Limited's business trend cannot be read yet. There are fewer than eight usable quarters of growth figures, so there is not enough history to read the trend. Why it matters: with too little history, we say so rather than guess a direction. One or more growth lines have an extreme jump caused by comparing with a near-zero or loss-making quarter. Those jumps are capped before reading and drawn at the edge of the chart, so one odd quarter does not decide the result. There are fewer than eight usable quarters, so this page does not guess a direction from so little history. ## How much does Prenetics Global Limited earn on its capital? Prenetics Global Limited earned a ROE of −26% in FY25. That is up from a low of −78% in FY22. Its return on capital used (ROIC) is 33.6 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a −43.3% net margin and 0.45× asset turnover (sales divided by assets). Why the return is what it is (FY25): a −43.3% net margin × 0.45× asset turnover × 1.32× leverage (assets divided by equity) ≈ −25.7% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: −27.1% − 6.5% = −33.6 percentage points. The 6.5% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. ## Does Prenetics Global Limited have too much debt? Prenetics Global Limited has total debt of $682 K against shareholder equity of $92.9 M as of Jun 2026, so its debt is 0.01× its equity, which is very little. Year by year, that ratio went from −1.23 in FY21 to 0.01 in FY25. So the returns on this page come from the business, not from borrowed money. ## What is the Prenetics Global Limited shareholding pattern? 4.1% of Prenetics Global Limited's tradable shares are in short positions, which are bets that the price will fall, so some traders are betting against it. At normal trading volumes, closing those positions would take about 2.7 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Prenetics Global Limited from balance-sheet trouble? For Prenetics Global Limited, the Z-score is not available, so we say so rather than guess one. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. The debt, cash-flow and return sections show the balance-sheet figures we do have, each with its own date. ## How does Prenetics Global Limited rank in its industry? There is no score against its industry: Prenetics Global Limited is not among the largest members shown in this industry comparison for Packaged Foods. The score ranks a company within its industry: each measure is scored against the other members. Without that group there is no score, so none is shown. ## Which companies is Prenetics Global Limited compared with? No sector comparison is shown here, not among the largest members shown in this industry comparison. ## Which companies are close to Prenetics Global Limited in size? Prenetics Global Limited is the 35th largest of 39 Packaged Foods companies on Sector Alpha by market value (scores of 3 November 2026). Just above it: Lifeway Foods, Inc., CN Healthy Food Tech Group Corp. and USANA Health Sciences, Inc. Just below it: Oatly Group AB, BRC Inc. and Nature's Sunshine Products, Inc. ### Packaged Foods companies close in size

1. [Lifeway Foods, Inc.](https://www.sectoralpha.in/us/stocks/lway) $336 million
2. [CN Healthy Food Tech Group Corp.](https://www.sectoralpha.in/us/stocks/ucfi) $288 million
3. [USANA Health Sciences, Inc.](https://www.sectoralpha.in/us/stocks/usna) $275 million
4. Prenetics Global Limited $274 million
5. [Oatly Group AB](https://www.sectoralpha.in/us/stocks/otly) $253 million
6. [BRC Inc.](https://www.sectoralpha.in/us/stocks/brcc) $244 million
7. [Nature's Sunshine Products, Inc.](https://www.sectoralpha.in/us/stocks/natr) $212 million

[All 39 Packaged Foods companies, largest first](https://www.sectoralpha.in/us/sectors/packaged-foods#all-companies)

### Companies close in size in other industries

1. [Sanara MedTech Inc.](https://www.sectoralpha.in/us/stocks/smti) $302 million · Medical Instruments & Supplies
2. [Fiverr International Ltd.](https://www.sectoralpha.in/us/stocks/fvrr) $302 million · Internet Content & Information
3. Prenetics Global Limited $301 million
4. [Titan International, Inc.](https://www.sectoralpha.in/us/stocks/twi) $300 million · Farm & Heavy Construction Machinery
5. [Gevo, Inc.](https://www.sectoralpha.in/us/stocks/gevo) $299 million · Specialty Chemicals

## What else do people ask about Prenetics Global Limited? ### What were Prenetics Global Limited Limited's latest quarterly results? Prenetics Global Limited reported revenue of $46.5 M and a net loss of $9.0 M for the Jun 2026 quarter. Earnings per share were −$0.52. The operating margin was −45.1%, 6.3 percentage points higher than a year earlier (as of 3 November 2026). ### What is Prenetics Global Limited Limited's market cap? Prenetics Global Limited's market capitalisation is $274 M at a stock price of $16.19. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 3 November 2026). ### How is Prenetics Global Limited Limited performing? Prenetics Global Limited's latest readings are below. Over the past 13 weeks it has done worse than the S&P 500, for 4 weeks running. This describes what the data did, not a rating (as of 3 November 2026). ### Will Prenetics Global Limited Limited's stock price go up? This page does not forecast Prenetics Global Limited's stock price. What it shows instead: the stock price is $16.19. Nobody can reliably say which way a price will move, and this site does not try (as of 3 November 2026). ### Where is Prenetics Global Limited Limited in its business cycle? Prenetics Global Limited's FY25 operating margin was −41.3%, against a 5-year range of −1,184.5% to −41.3%: the middle of its own range, neither a peak nor a low. The latest quarter was −45.1%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 3 November 2026). ### What could break the Prenetics Global Limited Limited story? Biggest thing to watch: the price is not yet in a clear uptrend, so timing is the risk more than the business. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 3 November 2026). ### Is Prenetics Global Limited Limited a stock worth studying right now? What the numbers show: Prenetics Global Limited's share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: the next one or two quarters of results. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 3 November 2026). This is research, not advice. We’re not SEBI-registered.